Lumigan

This page contains recent news articles, when available, and an overview of Lumigan but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

US Leading Dermatologists Review Latisse® Benefits for Eyelash Growth  -  ‎Jan 4, 2010‎
The post-marketing studies of Lumigan [an eye medication with the same active ingredient as Latisse and the more recent FDA pivotal studies for Latisse ... PR Web (press release)

It's a love/hate thing Many women swear it works, but the drug, developed to ...  -  ‎Dec 16, 2009‎
Latisse, originally a glaucoma drug marketed under the name Lumigan, was approved separately at the end of last year to enhance eyelashes, and its maker, ... Chicago Tribune

BTG Grants Allergan Rights to Gel-Based Drug-Delivery Technology for Use in ...  -  ‎Dec 18, 2009‎
Also under FDA review is Lumigan for glaucoma treatment and Zymar for eye-related infections. BTG is using ReGel in OncoGelâ„¢, its clinical-stage product ... Genetic Engineering News (press release)

The eyes have it: Lash treatments are the popular new trend in body care  -  ‎Dec 15, 2009‎
Doctors noticed that patients who used Latisse (formerly called Lumigan), which was originally prescribed to treat glaucoma, grew longer, more lush lashes. ... Philadelphia Inquirer

NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont®  -  ‎Dec 13, 2009‎
Inc. where he played a major role in the development of a number of high selling dermal and ophthalmic drugs such as Alphagan®, Lumigan® for glaucoma, ... PR-USA.net (press release)

Allergan Q3 2009 Earnings Call Transcript  -  ‎Oct 29, 2009‎
LUMIGAN in Japan which launched on October, LUMIGAN 0.1% in Europe indicated for First-Line Treatment to Glaucoma has been recommended for approval by the ... Seeking Alpha (blog)

Lumigan X EU Committee Recomendation  -  ‎Oct 28, 2009‎
This new version will be marketed as Lumigan-X after approval. Lumigan X offers Allergan a new formulation to compete against generic versions of its ... Gerson Lehrman Group

European authorities recommend granting Lumigan marketing approval in Europe  -  ‎Oct 23, 2009‎
..."We are pleased with the decision reached by the committee today to recommend Lumigan 0.01% for marketing authorization in Europe, which is an important ... OSN SuperSite

Lashing out at Latisse®  -  ‎Nov 3, 2009‎
Bimatoprost (Lumigan®) and latanoprost (Xalatan®) are members of the prostamide class of drugs that can manage some forms of glaucoma by reducing ... ScienceBlogs (blog)

CHMP issues latest recommendations, OK for Movetis' Resolor  -  ‎Oct 26, 2009‎
It has also backed Ratiopharm's version of Pfizer's erectile dysfunction blockbuster Viagra (sildenafil) and a new formulation of Allergan's Lumigan ... Pharma Times

FDA approves Allergan's drug for longer eyelashes  -  Dec 26, 2008
The active ingredient in Latisse is bimatroprost, the same ingredient that is in Allergan's glaucoma treatment Lumigan. Patients taking Lumigan found a side ... Reuters

Lash-Lengthener Latisse Is Glaucoma Drug Lumigan's Second Life  -  Dec 29, 2008
By RADHA CHITALE. Some people might look at Meiko Catron, a native of Japan, and find her tilted eyes exotic and attractive. But 61-year-old Catron, ... ABC News

DDMAC Warns Allergan for Misleading Lumigan Promotion  -  Sep 13, 2005
The FDA's advertising division has issued a warning letter to Allergan for disseminating misleading promotional materials for ocular treatment Lumigan. ... Pay-Per-View - Drug Industry Daily - Factiva, from Dow Jones

Allergan eyelash drug wins US panel backing  -  Dec 5, 2008
The drug is known generically as bimatoprost and is sold for glaucoma under the name Lumigan. Allergan estimates the eyelash use could fetch more than $500 ... Reuters UK

Allergan Announces FDA Approval of LUMIGAN(R) As First-Line …  -  Jun 23, 2006
Allergan, Inc. (NYSE:AGN) today announced that the United States Food and Drug Administration (FDA) has approved Allergan's once-daily prescription eye drop ... RedOrbit

Drug that lengthens eyelashes sets off flutter  -  Nov 19, 2007
At the same time, some doctors are writing Lumigan prescriptions for their ... Now, Dr. Klein promotes Lumigan on her Web site as "easy to use at home with ... OCRegister

FDA says glaucoma drug enhances eyelashes  -  Dec 3, 2008
The drug is already marketed under the name Lumigan, to treat eye conditions stemming from glaucoma. In studies for that treatment, researchers first ... msnbc.com

… European License for GANFORT(R) (LUMIGAN(R)/Timolol Combination) …  -  May 25, 2006
IRVINE, Calif. -- Allergan, Inc. (NYSE:AGN) today announced that it has received the license from the European Commission to market GANFORT(R), ... Free with registration - Business Wire - AccessMyLibrary.com

Lumigan.(Drug overview)  -  Jan 22, 2007
Lumigan is an eye drop that combats high pressure inside the eyeball. It is prescribed for a condition called open-angle glaucoma (a gradual increase of ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com

Allergan cites eyelash-drug fast dramatic effects  -  Jun 4, 2008
Pyott said noticeable results were seen as soon as three weeks for many patients given the medicine, a formulation of the drugmaker's widely used Lumigan ... Reuters India

Glaucoma Drug Doubles As Eyelash Enhancer  -  Dec 8, 2008
Allergan, which makes Botox anti-wrinkle injections, has asked the Food and Drug Administration to approve its Lumigan formula to enhance eyelashes for ... CBS News

Allergan Bats Its Lashes At Glaucoma Drug  -  Nov 19, 2007
At the same time, some docs are writing Lumigan off-label scripts for their ... Now, she promotes Lumigan on her Web site as “easy to use at home with only ... Pharmalot

Allergan Warned for Misleading Lumigan Promotion  -  Sep 19, 2005
Allergan has received an FDA warning letter for disseminating misleading promotional materials for its ocular treatment Lumigan. The Sept. ... Pay-Per-View - Washington Drug Letter - Factiva, from Dow Jones

… AGN's Once-Daily Prescription Eye Drop LUMIGAN 0.03% As First-Line...  -  Jun 23, 2006
...open-angle glaucoma or ocular hypertension. The LUMIGAN first-line indication is in addition to LUMIGAN's widely established use as a second-line treatment. StreetInsider.com - StreetInsider.com (subscription)

Lumigan.(NEW INDICATIONS)(Brief article)  -  Jul 24, 2006
Allergan Inc., Irvine, Calif., (714) 246-4500, has received FDA approval for Lumigan (bimatoprost ophthalmic solution) 0.03% as a first-line treatment for ... Free with registration - Drug Topics - AccessMyLibrary.com

… Data(1) Show Efficacy of Treatment With Lumigan for Intraocular...  -  Dec 11, 2007
New Head to Head Data(1) Show Efficacy of Treatment With Lumigan for Intraocular Pressure - Key Risk Factor for Glaucoma.(Clinical report) from PR Newswire ... Pay-Per-View - PR Newswire Europe - HighBeam Research

… Positive Opinion for GANFORT(R) (LUMIGAN(R)/Timolol Combination)...  -  Mar 24, 2006
Allergan, Inc. (NYSE:AGN) today announced that the Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission ... RedOrbit

… pressure.(NEW INDICATIONS)(Food and Drug Administration)(Lumigan) …  -  Aug 1, 2006
The Lumigan first-line indication is in addition to Lumigan's widely ... Allergan (allergan.com) received approval from FDA for Lumigan in 2001 as an ... Pay-Per-View - Med Ad News - Factiva, from Dow Jones

FDA Approvals: Lumigan, Cesamet, Omnitrope  -  Jul 14, 2006
July 14, 2006 — The US Food and Drug Administration (FDA) has approved an expanded indication for bimatoprost 0.03% ophthalmic solution, allowing its ... Medscape

Drug that lengthens eyelashes sets off a flutter  -  Nov 24, 2007
At the same time, some doctors are writing Lumigan prescriptions for their ... Now, Klein promotes Lumigan on her Web site as "easy to use at home with only ... Chicago Daily Herald - Chicago Daily Herald

Allergan Lashes Out  -  Jun 6, 2008
Over time, Allergan noticed that patients taking another one of its eyedrop treatments, Lumigan, were experiencing noticeable eyelash growth. ... Money Times - The Money Times

Lumigan.  -  Jul 24, 2006
This first-line indication, supporting the initial use of Lumigan for these indications, is in addition to Lumigan's established use as a second-line ... $9.94 - Drug Topics - Alacra Store

A drug for longer lashes?  -  Jun 10, 2008
Increased eyelash growth is one of the commonest side-effects of Lumigan, which in 2001 was approved in the US as a glaucoma treatment to reduce pressure ... Chemistry World

FDA APPROVES ALLERGAN'S LUMIGAN FOR IOP TREATMENT  -  Jun 27, 2006
The FDA has approved Allergan's once-daily prescription eyedrops Lumigan as a first-line treatment for elevated intraocular pressure (IOP) associated with ... Pay-Per-View - FDAnews Drug Pipeline Alert - Factiva, from Dow Jones

眼è?¯é•¿ç?«æ¯›å°?心副作用  -  Nov 25, 2007
...美国眼力å?¥åˆ¶è?¯æœ‰é™?å…¬å?¸ç”Ÿäº§çš„æ²»ç–—é?’光眼的处方è?¯Lumigan,由于其副作用å?¯ä»¥å¯¼è‡´ ... 然而,英国和美国医è?¯ç®¡ç?†éƒ¨é—¨æ??醒爱美女士,Lumigan还有其他副作用,严é‡?情况下 ... æ–°å?Žç½‘

Bright future for NicOx after Pfizer glaucoma deal  -  Mar 10, 2006
Alcons Travatan and Allergans Lumigan are two other top-selling glaucoma products and are also enjoying fast sales growth. Pharmafocus

眼藥長ç?«æ¯›å°?心副作用  -  Nov 25, 2007
...美國眼力å?¥åˆ¶è—¥æœ‰é™?å…¬å?¸ç”Ÿç”¢çš„æ²»ç™‚é?’光眼的處方藥Lumigan,由于其副作用å?¯ä»¥å°Žè‡´ ... 然而,英國和美國醫藥管ç?†éƒ¨é–€æ??醒愛美女士,Lumigan還有其他副作用,嚴é‡?情æ³?下 ... æ–°è?¯ç¶²

Pengarna tillbaka om Lumigan inte fungerar  -  Aug 15, 2005
Företaget Allergan erbjuder från och med idag pengarna tillbaka till patienter och landsting om det visar sig att företagets glaukomläkemedel bimatoprost ... Läkemedelsvärlden

滥用ç?«æ¯›å¢žé•¿æ¶²æˆ–致失明(组图)  -  Dec 11, 2007
...一年�,美国眼力�公�生产了一�治疗�光眼的处方�Lumigan(�美根),其中一� ... 但眼力�公���声明称,Lumigan(�美根)眼�会有其他副作用,让眼��红��痒 ... 央视国际

Britânicas usam remédio contra glaucoma para aumentar cílios  -  Nov 27, 2007
..."O Lumigan é um remédio de venda sob receita médica e não deveria ser usado por ... O Times observa que o Lumigan é fabricado pela farmacêutica californiana ... Estadão

Event Brief of Q2 2005 Allergan Earnings Conference Call - Final.  -  Jul 27, 2005
Ex-factory Lumigan sales increased in dollars by 7% in 2Q05 YoverY and has ... Encouragingly however, global end market sales of Lumigan increased by 16% in ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Longer, Thicker, Darker Eyelashes: No Surgery Required  -  Jan 21, 2008
Two other drugs of its kind exist but Lumigan has shown to be the most effective when used ... Discouraging to some, Lumigan may result in adverse effects. ... Ivanhoe Broadcast News

All Eyes On The Family For Glaucoma  -  Jul 10, 2007
LUMIGAN® has been reported to cause darkening of eye color, eyelid skin and ... Pigmentation is expected to increase as long as LUMIGAN® is administered. ... Imperial Valley News

Fármaco para el crecimiento de las pestañas funciona en 8 de cada 10 ...  -  Jun 4, 2008
Las gotas Lumigan se colocan directamente en el ojo y combaten el glaucoma reduciendo la presión dentro del globo ocular. La nueva fórmula en cambio, ... La Tercera

滥用ç?«æ¯›å¢žé•¿æ¶²å?¯è‡´å¤±æ˜ŽæµŽå?—化妆店ä»?在å?–  -  Nov 27, 2007
...但眼力�公���声明称,Lu�ig�n (�美根)眼�会造�其他副作用,让眼�� 红��痒 ... 这则消�称美国眼力�制�有�公�生产的治疗�光眼的处方�Lumigan( ... 舜网

â–’ NO1.뉴미디어'마ì?´ë?°ì?¼ë¦¬ â–’  -  Dec 6, 2008
...[메디컬투�� 곽�� 기�] 앨러간사� 녹내장 치료제 '루미간(Lumigan)' ��는 약물� �눈�� 연장시키는�� 효과��면서 안전한 것으로 나타났다. ... 마���리

FDA asks Allergan to withdraw eye drug sales aid  -  Sep 8, 2005
WASHINGTON (Reuters) - The Food and Drug Administration has asked Allergan Inc. to withdraw promotional material for its Lumigan eyedrops to treat glaucoma ... RedOrbit

От капель нечаÑ?нно выроÑ?ли реÑ?ницы  -  Dec 11, 2008
Ð?налог проÑ?тагландинов биматопроÑ?Ñ‚, который ранее продавалÑ?Ñ? под торговым названием “Lumiganâ€? в виде глазных капель длÑ? лечениÑ? глаукомы, был иÑ?пытан по ... ГÐ?ЗЕТÐ?.GZT.ru

Όταν τα φάÏ?μακα γίνονται καλλυντικά: Το Lumigan μεγαλώνει τις βλε  -  Nov 26, 2007
Μια από τις «ανεπιθÏ?μητες» ενέÏ?γειες του φαÏ?μάκου Lumigan είναι το ότι μεγαλώνει τις βλεφαÏ?ίδες. Από τη στιγμή που έγινε γνωστό αυτό, αÏ?κετές εταιÏ?είες ... Madata.GR

FDA одобрило первый препарат длÑ? Ñ?тимулÑ?ции роÑ?та реÑ?ниц  -  Dec 30, 2008
Ранее биматопроÑ?Ñ‚ выпуÑ?калÑ?Ñ? лишь в форме глазных капель под названием «Lumigan», предназначенных длÑ? лечениÑ? глаукомы. КлиничеÑ?кие иÑ?Ñ?ледованиÑ? подтвердили ... ВерÑ?ии.Ñ?ом

… .- El tratamiento del glaucoma con 'Lumigan' (Allergan) proporciona...  -  Apr 7, 2008
El tratamiento del glaucoma con 'Lumigan' (bimatoprost 0,03%), comercializado por Allergan, proporciona al paciente una presión intraocular ... ecodiario

Eyelash Enhancer?  -  Feb 22, 2007
The drug is Lumigan; it is one of three commonly prescribed glaucoma ... Luanne says after just one week of using Lumigan, friends say they can see a ... go.com

… DEL GLAUCOMA CON LUMIGAN® PROPORCIONA A LOS PACIENTES …  -  May 5, 2008
Un estudio de la American Society of Cataract and Refractive Surgery (ASCRS, Sociedad Americana de Cataratas y Cirugía Refractiva), demuestra que el ... acceso.com

GENVEC GETS FDA CLEARANCE TO RESUME PHASE II TNFERADE …  -  Jul 1, 2005
Article: STUDY SHOWS LUMIGAN MORE EFFECTIVE THAN XALATAN. ... The data indicate that both LUMIGAN(TM) ophthalmic solution once-a-day and ... therapy, ... Pay-Per-View - Biotech Business - HighBeam Research

Lash-lengthening drug could soon replace mascara  -  Jun 23, 2008
In addition to being an effective glaucoma drug, Lumigan has dramatic cosmetic ... Lumigan stops progression of the disease by reducing pressure in the eye. Toronto Star

Long Beach Press-Telegram : U<br>  -  Jun 30, 2008
It happened when users of Lumigan, a medication manufactured by Allergan ... As a glaucoma medication, Lumigan works by reducing pressure inside the eye. ... $3.50 - Press Telegram - NewsBank

… .- El tratamiento del glaucoma con 'Lumigan' (Allergan) proporciona...  -  Apr 7, 2008
El tratamiento del glaucoma con 'Lumigan' (bimatoprost 0,03%), comercializado por Allergan, proporciona al paciente una presión intraocular ... ecodiario

ЛекарÑ?тво от глаукомы оказалоÑ?ÑŒ Ñ?ффективным Ñ?тимулÑ?тором ро?  -  Dec 10, 2008
Ð?налог проÑ?тагландинов биматопроÑ?Ñ‚, продаваемый под торговым названием «Lumigan» в форме глазных капель длÑ? лечениÑ? глаукомы, был иÑ?пытан по новому ... МедÐ?овоÑ?ти.ру

Hold the mascara; Drug has potential to grow thicker, longer lashes  -  Jun 30, 2008
Lumigan has dramatic cosmetic effects, says a doctor who specializes in ... Lumigan stops progression of the disease by reducing pressure in the eye. ... Pay-Per-View - The Spectator - ProQuest Archiver

Event Brief of Q4 2005 Allergan Earnings Conference Call - Part 1.  -  Feb 2, 2006
Global market share gains driven by Restasis, Lumigan, Combigan, ... Lumigan growth continued, growing 15% in dollars, 16% constant currency in 4Q05, ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

Drug could help grow eyelashes  -  Nov 20, 2008
The active ingredient in Lumigan is called bimatoprost. It's part of a class of drugs called prostaglandins. There are other glaucoma drugs with ... go.com

Lash booster's plot thickens  -  Jul 28, 2008
It happened when users of Lumigan, a medication manufactured by Allergan ... As a glaucoma medication, Lumigan works by reducing pressure inside the eye. ... OCRegister

FDA ACCEPTS ANTARES LICENSEE'S NDA FOR BIO-E-GEL. | Article …  -  Jun 1, 2006
Article: STUDY SHOWS LUMIGAN MORE EFFECTIVE THAN XALATAN. ... The data indicate that both LUMIGAN(TM) ophthalmic solution once-a-day and ... therapy, ... Pay-Per-View - Biotech Business - HighBeam Research

Q1 2006 Allergan Earnings Conference Call - Part 2.  -  May 3, 2006
First, in terms of Lumigan, we are fortunate to have a product that lowers pressure better than the other prostaglandin and analogues. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

Event Brief of Q2 2007 Allergan Earnings Conference Call - Final.  -  Aug 1, 2007
In US, filed LUMIGAN X, next-generation LUMIGAN product. 1. Partner Senju, in Japan, also filed LUMIGAN with MHLW. 8. Next-generation advanced platform ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Agency A-to-Z: the indispensable guide to healthcare agencies,...  -  Jul 1, 2006
This ad clearly communicates that LUMIGAN has the staying power to keep lOP down when first-line therapy allows pressure to "drift." Palio Communications ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com

Event Brief of Q3 2005 Allergan Earnings Conference Call - Part 1.  -  Nov 1, 2005
Lumigan. 4. The tears product range led by Refresh, Tazorac, Acular LS, and Zymar. 5. ... Global market share gains are being driven by Restasis, Lumigan, ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

Druppels voor langere wimpers  -  Dec 29, 2008
Toen Lumigan werd getest voor patiënten met glaucoom (groene staar), ... Zo werd bij de testen met Lumigan bijvoorbeeld vastgesteld dat patiënten de kleur ... Knack

Event Brief of Q3 2007 Allergan Earnings Conference Call - Final.  -  Nov 6, 2007
Growth is almost as high as LUMIGAN at 15% YTD. 8. ... COMBIGAN, LUMIGAN, recent introduction of GANFORT and share gains with artificial tear line. 11. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Who's the boss of patient's care? A patient with advanced glaucoma...  -  Nov 15, 2005
Current medications include Lumigan (bimatoprost, Allergan) one drop hs OU, ... She was initially managed with Betagan for several years, then Lumigan was ... Free with registration - Review of Optometry - AccessMyLibrary.com

The Pfizer-Allergan Deal Worst-Case Scenario  -  Dec 5, 2008
Its Lumigan/Latisse new drug application, in which the glaucoma drug is being ... Second, Allergan estimates peak sales of $500 million for Lumigan if it ... BNET

Orange County Business Journal Online  -  Feb 4, 2008
Besides Sanctura XR, they include Lumigan X, a glaucoma drug that's a second-generation version of Allergan's original Lumigan, he said. ... Orange County Business Journal - Orange County Business Journal

The eye disease drug that gives you longer lashes  -  Oct 27, 2008
Interest in the cosmetic potential of Lumigan was sparked by the observation that the lashes of many patients being treated for glaucoma grew more quickly ... Daily Mail

Kenya: Tale of Bald Sons-in-Laws, And Stolen Elections  -  Dec 13, 2007
The Times (London) reports that Lumigan, a drug used to treat glaucoma, ... In Britain prescriptions for Lumigan have shot up by 40 per cent and it has ... AllAfrica.com

Smooth operators: how does a cream tested on 21 women in Virginia hit...  -  Feb 1, 2005
Shortly thereafter, Allergan, the company that makes Lumigan (and Botox) and is in the process of creating its own lash-strengthening product, filed ... ... Pay-Per-View - W - HighBeam Research

Schönheitswahn: Neues "Wundermittel" lässt Augenwimpern sprießen  -  Jun 4, 2008
Botox wurde zur Bekämpfung von Muskelkrämpfen angewandt, Lumigan sollte den ... Bei Lumigan hingegen wurde ein verstärktes Wachstum der Augenwimpern ... WirtschaftsBlatt.at

Some nutrients can give a boost in the reproductive race  -  Mar 1, 2006
My husband is on Plavix, Lovistatin and Lumigan. I take no medications. We are both healthy. Thank you. Ed Blonz, Ph.D., is a nutritional scientist based in ... Pay-Per-View - San Diego Union - Tribune - ProQuest Archiver

People news from the 09/12/06 News Brief  -  Sep 12, 2006
Rowe will oversee the account management for both the Lumigan and Combigan accounts. Prior to her promotion, Rowe was the account supervisor for Lumigan. ... Medical Marketing & Media - Medical Marketing and Media

FDA approves Allergan's eyelash-growth drug  -  Dec 29, 2008
The FDA has approved another indication for Allergan's seven-year old drug Lumigan (bimatoprost). Doctors and patients noticed that the glaucoma treatment ... FiercePharma

Eternal eyeliner | makeup, permanent, tattoo, tattooed, patients -...  -  Oct 13, 2008
All I do is put on sunscreen and anti-aging moisturizers plus a little mascara (less since I enhanced my lashes with Lumigan) and I'm out the door!" ... OCRegister

The cost of doing business: an 84-year-old patient is newly diagnosed...  -  Feb 15, 2007
Subsequent visits to the present day have demonstrated IOPs averaging 13mm Hg OD and 12mm Hg OS while medicated with Lumigan. Reliable threshold fields were ... Free with registration - Review of Optometry - AccessMyLibrary.com

News.(Alcon Laboratories (UK) Ltd. launches Travatan in a new pack)( …  -  Mar 16, 2007
...cost savings when compared to Lumigan ([pounds sterling]32.66 for triple pack) ... or prescribing Travatan rather than Lumigan is [pounds sterling]3085.12. Free with registration - Optician - AccessMyLibrary.com

Medicure Appoints Vice President of Research and Development  -  Jul 12, 2006
The combined sales for Alphagan ® and Lumigan ® in 2005 exceeded US$400 million. He is the sole or co-inventor on over 75 patents issued in the US, ... ccnmatthews.com

Orange County Business Journal Online  -  May 14, 2007
Restasis, Allergan's dry eye treatment, Lumigan, a glaucoma drug, and even Botox “will likely take a back seat again,� said Elliot Wilbur and Katherine Lu ... Orange County Business Journal - Orange County Business Journal

Aprueba la FDA fármaco que engrosa las pestañas  -  Dec 27, 2008
El ingrediente activo del fármaco es el bimatroprost, el mismo que utiliza el medicamento contra el glaucoma Lumigan, también de Allergan. ... La Jornada - La Jornada (México)

Allergan Reports Second Quarter Operating Results; Total Product Net ...  -  Aug 2, 2006
GANFORT(R) is Allergan's LUMIGAN(R)/timolol combination product (bimatoprost/timolol ophthalmic solution) for the treatment of glaucoma, and is indicated ... $4.95 - Business Wire - ECNext

滥用ç?«æ¯›å¢žé•¿æ¶²ä¼šå¯¼è‡´çœ¼ç?›å¤±æ˜Ž(组图)  -  Dec 17, 2007
...但眼力å?¥å…¬å?¸éš?å?Žå£°æ˜Žç§°ï¼ŒLumigan(å?¢ç¾Žæ ¹)眼è?¯ä¼šé€ æˆ?其他副作用,让眼ç?›å?‘红ã€?å?‘ç—’ ... 英美医è?¯ç®¡ç?†éƒ¨é—¨ä¹Ÿæ??出警告:Lumigan还有其他副作用,严é‡?者å?¯å¯¼è‡´å¤±æ˜Žï¼Œå»ºè®® ... 新浪网

ΠÏ?ωτοποÏ?ιακό φάÏ?μακο χαÏ?ίζει πυκνές βλεφαÏ?ίδες  -  Dec 29, 2008
Όπως αναφέÏ?ει το Reuters, το φάÏ?μακο πεÏ?ιέχει την ουσία bimatroprost, η οποία είναι το δÏ?αστικό συστατικό και στο φάÏ?μακο Lumigan της Allergan κατά του ... Το Βήμα Online

å…¨ç?ƒé¦–个促ç?«æ¯›ç”Ÿé•¿å¤„æ–¹è?¯;有望获批  -  Dec 30, 2008
Latisse是�光眼治疗�物Lumigan的“孪生�妹�,Lumigan滴眼液2001年获得FDA批准。 在试验中,137例�试者给予Latisse治疗,141例�试者应用安慰剂溶液16周。 ... �日甘肃

Feeling the pinch: slight gains in ad spending were reported among...  -  May 1, 2008
Allergan's Lumigan dropped from 2nd to 4th as ad outlays fells by 22% and Alcon's Vigamox slipped from 4th to 5th even though ad spending was up by 7%. ... $20.00 - Medical Marketing & Media - Alacra Store

Pacific Communications.(AGENCIES)(promotions of Ruby Rowe)(Brief …  -  Nov 1, 2006
Rowe will oversee the account management for both the Lumigan and Combigan accounts. Prior to her promotion, Rowe was the Account Supervisor for Lumigan. ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Top 300 single-source brand drugs by manufacturer and NDC11 number. …  -  Apr 28, 2008
Keppra50474059640 284Allergan Lumigan 00023918703 285Allergan Zymar 00023921805 286Novartis Gleevec 00078040105 287Wyeth Pharm. ... Pay-Per-View - Chain Drug Review - HighBeam Research

Botox promotions investigated.(Policy & Practice) | Article from Skin...  -  Apr 1, 2008
Lumigan, which will have an estimated $450 million in sales in 2008. ... Allergan markets bimatoprost under the trade name Lumigan. ... Pay-Per-View - Skin & Allergy News - HighBeam Research

Lash out.(Uncensored) | Article from W | HighBeam Research  -  Mar 1, 2008
Shortly thereafter, Allergan, the company that makes Lumigan (and Botox) and is in the process of creating its own lash-strengthening product, ... Pay-Per-View - W - HighBeam Research

Article: Eyelash product containing glaucoma drug seized.(News)  -  Jan 1, 2008
Meanwhile, Allergan, the manufacturer of Lumigan, the prescription product that ... She would not comment on reports that Allergan is testing Lumigan for a ... Pay-Per-View - Family Practice News - HighBeam Research

FINAL TRANSCRIPT  -  May 7, 2008
...products, RESTASIS, the Alphagan family including Combigan, Lumigan, ... In Thailand, Lumigan. was selected as the only (inaudible) in analog in the ... $54.00 - Thomson StreetEvents - Alacra Store

Article: Allergan seeks eyelash drug OK.(Policy & Practice) - Skin & ...  -  Jul 1, 2008
Bimatoprost is the active ingredient in Lumigan, the company's glaucoma drug and a synthetic ... That would put it on par with Lumigan, which will ... ... Pay-Per-View - Skin & Allergy News - HighBeam Research

Cosmeceuticals: the line blurs.(Editor's Page)  -  Dec 1, 2007
Seems that Bimatoprost, the active ingredient in Allergan's Lumigan, actually grows eyelashes and that's a most welcome side effect for some folks. ... $4.95 - Household & Personal Products Industry - ECNext

Global top 300 brand-name pharmaceuticals by sales, manufacturer, and...  -  Apr 28, 2008
Keppra 50474059640 284 Allergan Lumigan 00023918703 285 Allergan Zymar 00023921805 286 Novartis Gleevec 00078040105 287 Wyeth Pharm. ... $20.00 - Chain Drug Review - Alacra Store

Article: HEALTH : Threat to eyesight.(Features) - The Birmingham Post...  -  Sep 3, 2005
Article: LUMIGAN Outcome Favorable in Comparison Study with Xalatan; ... ... The data indicate that both LUMIGAN(TM) ophthalmic solution once-a-day ... ... Pay-Per-View - Birmingham Post - HighBeam Research

Article: Early testing and treatment can help overcome glaucoma - …  -  Mar 5, 2008
Article: Lumigan 6-Month Phase III Data Presented at American ... Business Wire; March 2, 2001 ; 700+ words ... ... 0.03%, a synthetic prostamide, ... Pay-Per-View - Jerusalem Post - HighBeam Research

The Columbus Dispatch - Local/State | The Columbus Dispatch  -  Dec 5, 2005
Trusopt, Azopt, Xalatan and Lumigan are glaucoma medicines that can be used in place of timolol. Q: My doctor has me on hydrocortisone because of ... Columbus Dispatch

Pop Singer Starts Venture Fund  -  Dec 26, 2008
The drug is already sold under the name Lumigan to treat eye conditions stemming from glaucoma. Allergan expects peak annual sales of Latisse to reach $500 ... Washington Post

Wednesday's Health Winners & Losers  -  Oct 31, 2007
Allergan also makes Lumigan and Alphagan for glaucoma. Novavax (NVAX - commentary - Cramer's Take) tacked on 68 cents, or 19.3%, to $4.20, after Oppenheimer ... TheStreet.com - TheStreet.com (subscription)

Mulheres colocam a própria visão em risco por vaidade  -  Oct 12, 2008
A Allergan, fabricante do Lumigan, testa a droga e tenta viabilizá-la para o tratamento de perda de cílios, mas ainda vai demorar um longo tempo para ... Jornal da Cidade

Netherlands Corporate News - Allergan krijgt positief oordeel voor …  -  Mar 27, 2006
BW)(CA-ALLERGAN)(AGN) Allergan krijgt positief oordeel voor GANFORT(R) (combinatie LUMIGAN(R)/Timolol)in Europese Unie Farmaceutisch ... Netherlands Corporate News - Netherlands Corporate News (persbericht)

Chemische mascara  -  Dec 4, 2008
Lumigan (bimatoprost) is een synthetisch prostaglandine-analoog. Het is ontwikkeld om de oogdruk te verminderen bij mensen die lijden aan de oogziekte ... C2W

… licencia paneuropea para GANFORT(R) (combinación de LUMIGAN(R)/ …  -  May 25, 2006
...el producto de combinación de LUMIGAN(R)/timolol de Allergan (solución oftálmica de bimatoprost/timolol) para el tratamiento del glaucoma, ... elEconomista.es

КомпаниÑ? Allergan выводит на американÑ?кий рынок Ñ?редÑ?тво длÑ? роÑ? …  -  Jun 9, 2008
Как Ñ?ообщают зарубежные Интернет-иÑ?точники, новинка называетÑ?Ñ? Lumigan. ... Отметим, что ранее оÑ?новной компонент Lumigan – биматопроÑ?Ñ‚ – иÑ?пользовалÑ?Ñ? в ... коÑ?метичеÑ?кий портал Cosmomir.ru

Netherlands Corporate News - Allergan krijgt pan-Europese vergunning ...  -  May 25, 2006
BW)(CA-ALLERGAN-INC)(AGN) Allergan krijgt pan-Europese vergunning voor GANFORT® (LUMIGAN®/Timolol combinatie) van Europese Commissie Farmaceutische ... Netherlands Corporate News - Netherlands Corporate News (persbericht)





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy